Perrigo | PRGO - Stock


Perrigo reported $1.12B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Abbott USD 6.99B 501M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Dr.Reddys Laboratories INR 79.01B 3.19B Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
J&J USD 14.58B 392M Mar/2026
Merck USD 6.48B 179M Mar/2026
Nestle CHF 12.81B 1.62B Dec/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 159.13M 4.46M Mar/2026
Reckitt Benckiser GBP 1.62B 101M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zoetis USD 2.55B 120M Mar/2026